RNA5SP464: A Potential Drug Target and Biomarker (G100873708)

RNA5SP464: A Potential Drug Target and Biomarker

RNA5SP464 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the cell cycle and is involved in various cellular processes, including cell growth, apoptosis, and inflammation. The RNA5SP464 gene has been shown to have association with various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Drug Target Potential

RNA5SP464 has been identified as a potential drug target due to its involvement in various cellular processes that are associated with the development and progression of diseases. One of the key reasons for its potential as a drug target is its involvement in the cell cycle. RNA5SP464 is a key regulator of the G1/S transition, which is a critical step in the cell cycle that is associated with cell growth and division. Therefore, inhibiting the activity of RNA5SP464 could lead to a reduction in cell proliferation, which could be a potential mechanism of action for a drug that targets RNA5SP464.

In addition to its involvement in the cell cycle, RNA5SP464 is also involved in apoptosis, which is a natural process that helps the body to eliminate damaged or dysfunctional cells. The loss of apoptosis regulation has been implicated in the development and progression of various diseases, including cancer. Therefore, targeting RNA5SP464 could also be a potential mechanism of action for a drug that targets apoptosis.

Biomarker Potential

RNA5SP464 has also been identified as a potential biomarker for various diseases. Its involvement in the cell cycle and apoptosis make it an attractive target for drugs that target these processes. In addition, RNA5SP464 has been shown to be involved in the regulation of cellular immune responses, which could make it an attractive target for drugs that target autoimmune disorders.

Furthermore, RNA5SP464 has also been shown to be involved in the regulation of cellular signaling pathways, including the TGF-β pathway. This pathway is involved in the regulation of cell growth, differentiation, and inflammation, and has been implicated in various diseases, including cancer. Therefore, targeting RNA5SP464 with drugs that inhibit TGF-β signaling could also be a potential mechanism of action for a drug that targets RNA5SP464.

Conclusion

In conclusion, RNA5SP464 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its involvement in the cell cycle, apoptosis, and inflammation make it an attractive target for drugs that target these processes. In addition, RNA5SP464 has also been shown to be involved in the regulation of cellular signaling pathways, which could make it an attractive target for drugs that target these processes. Further research is needed to fully understand the potential mechanisms of action of RNA5SP464 as a drug target and biomarker.

Protein Name: RNA, 5S Ribosomal Pseudogene 464

The "RNA5SP464 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNA5SP464 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

RNA5SP465 | RNA5SP479 | RNA5SP493 | RNA5SP496 | RNA5SP497 | RNA5SP505 | RNA5SP511 | RNA5SP518 | RNA5SP52 | RNA5SP53 | RNA5SP54 | RNA5SP57 | RNA5SP63 | RNA5SP85 | RNA5SP91 | RNASE1 | RNASE10 | RNASE11 | RNASE11-AS1 | RNASE12 | RNASE13 | RNASE2 | RNASE2CP | RNASE3 | RNASE4 | RNASE6 | RNASE7 | RNASE8 | RNASE9 | RNASEH1 | RNASEH1-DT | RNASEH2A | RNASEH2B | RNASEH2B-AS1 | RNASEH2C | RNASEH2CP1 | RNASEK | RNASEL | RNASET2 | RND1 | RND2 | RND3 | RNF10 | RNF103 | RNF103-CHMP3 | RNF11 | RNF111 | RNF112 | RNF113A | RNF113B | RNF114 | RNF115 | RNF121 | RNF122 | RNF123 | RNF125 | RNF126 | RNF126P1 | RNF128 | RNF13 | RNF130 | RNF133 | RNF135 | RNF138 | RNF138P1 | RNF139 | RNF139-DT | RNF14 | RNF141 | RNF144A | RNF144B | RNF145 | RNF146 | RNF148 | RNF149 | RNF150 | RNF151 | RNF152 | RNF157 | RNF157-AS1 | RNF165 | RNF166 | RNF167 | RNF168 | RNF169 | RNF17 | RNF170 | RNF175 | RNF180 | RNF181 | RNF182 | RNF183 | RNF185 | RNF186 | RNF187 | RNF19A | RNF19B | RNF2 | RNF20 | RNF207